vs
Side-by-side financial comparison of GREENPOWER MOTOR Co INC. (GP) and NovaBay Pharmaceuticals, Inc. (NBY). Click either name above to swap in a different company.
GREENPOWER MOTOR Co INC. is the larger business by last-quarter revenue ($7.2M vs $4.8M, roughly 1.5× NovaBay Pharmaceuticals, Inc.). NovaBay Pharmaceuticals, Inc. runs the higher net margin — -25.5% vs -65.6%, a 40.1% gap on every dollar of revenue. On growth, NovaBay Pharmaceuticals, Inc. posted the faster year-over-year revenue change (126.1% vs -11.5%).
GreenPower Motor Company Inc. is a Canadian electric bus manufacturer and distributor in North America. The company fabricates multiple zero-emission models, including transit buses, school buses, and double decker buses. GreenPower headquarters are in Vancouver, British Columbia, with a sales office in Rancho Cucamonga, California; an assembly facility in Porterville, California; and a production facility in South Charleston, West Virginia. Its stock is traded on Nasdaq the United States.
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis
GP vs NBY — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $7.2M | $4.8M |
| Net Profit | $-4.7M | $-1.2M |
| Gross Margin | 14.6% | 65.2% |
| Operating Margin | — | -37.2% |
| Net Margin | -65.6% | -25.5% |
| Revenue YoY | -11.5% | 126.1% |
| Net Profit YoY | -2.1% | 70.5% |
| EPS (diluted) | $-0.17 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 24 | $7.2M | $4.8M | ||
| Q3 24 | $5.3M | $0 | ||
| Q2 24 | $3.0M | $2.4M | ||
| Q1 24 | — | $2.6M | ||
| Q4 23 | $8.2M | $2.1M | ||
| Q3 23 | $8.4M | $2.5M | ||
| Q2 23 | $17.6M | $3.5M | ||
| Q1 23 | — | $2.3M |
| Q4 24 | $-4.7M | $-1.2M | ||
| Q3 24 | $-4.7M | $-1.2M | ||
| Q2 24 | $-5.4M | $-1.6M | ||
| Q1 24 | — | $-3.2M | ||
| Q4 23 | $-4.6M | $-4.1M | ||
| Q3 23 | $-4.3M | $-1.8M | ||
| Q2 23 | $-2.8M | $-2.0M | ||
| Q1 23 | — | $-1.7M |
| Q4 24 | 14.6% | 65.2% | ||
| Q3 24 | 8.6% | — | ||
| Q2 24 | 7.4% | 66.3% | ||
| Q1 24 | — | 68.2% | ||
| Q4 23 | 16.6% | 51.5% | ||
| Q3 23 | 14.6% | 67.0% | ||
| Q2 23 | 15.9% | 49.2% | ||
| Q1 23 | — | 68.4% |
| Q4 24 | — | -37.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -67.4% | ||
| Q1 24 | — | -87.1% | ||
| Q4 23 | — | -48.0% | ||
| Q3 23 | — | -28.1% | ||
| Q2 23 | — | -29.7% | ||
| Q1 23 | — | -57.5% |
| Q4 24 | -65.6% | -25.5% | ||
| Q3 24 | -87.9% | — | ||
| Q2 24 | -179.8% | -66.0% | ||
| Q1 24 | — | -122.2% | ||
| Q4 23 | -56.9% | -195.5% | ||
| Q3 23 | -50.4% | -70.8% | ||
| Q2 23 | -16.0% | -57.6% | ||
| Q1 23 | — | -74.3% |
| Q4 24 | $-0.17 | — | ||
| Q3 24 | $-0.18 | $-1.92 | ||
| Q2 24 | $-0.21 | $-1.37 | ||
| Q1 24 | — | $-29.95 | ||
| Q4 23 | $-0.19 | — | ||
| Q3 23 | $-0.17 | — | ||
| Q2 23 | $-0.11 | — | ||
| Q1 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $621.1K | $430.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.1M | $-129.0K |
| Total Assets | $37.4M | $3.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 24 | $621.1K | $430.0K | ||
| Q3 24 | $116.9K | $776.0K | ||
| Q2 24 | $528.3K | $751.0K | ||
| Q1 24 | — | $1.8M | ||
| Q4 23 | $4.0M | $2.9M | ||
| Q3 23 | $2.0M | $3.5M | ||
| Q2 23 | $1.5M | $4.4M | ||
| Q1 23 | — | $3.7M |
| Q4 24 | $2.1M | $-129.0K | ||
| Q3 24 | $4.2M | $1.1M | ||
| Q2 24 | $8.6M | $-617.0K | ||
| Q1 24 | — | $160.0K | ||
| Q4 23 | $18.1M | $3.3M | ||
| Q3 23 | $22.3M | $7.0M | ||
| Q2 23 | $26.2M | $8.6M | ||
| Q1 23 | — | $8.9M |
| Q4 24 | $37.4M | $3.4M | ||
| Q3 24 | $39.4M | $3.9M | ||
| Q2 24 | $43.5M | $3.9M | ||
| Q1 24 | — | $5.4M | ||
| Q4 23 | $50.2M | $9.0M | ||
| Q3 23 | — | $12.9M | ||
| Q2 23 | — | $16.0M | ||
| Q1 23 | — | $14.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.1M | $-1.7M |
| Free Cash FlowOCF − Capex | — | $-1.7M |
| FCF MarginFCF / Revenue | — | -35.4% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 24 | $-1.1M | $-1.7M | ||
| Q3 24 | $-1.3M | $-2.4M | ||
| Q2 24 | $-3.2M | $-1.4M | ||
| Q1 24 | — | $-2.0M | ||
| Q4 23 | $1.4M | $-592.0K | ||
| Q3 23 | $-5.4M | $-646.0K | ||
| Q2 23 | $7.8M | $-1.7M | ||
| Q1 23 | — | $-1.2M |
| Q4 24 | — | $-1.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-2.0M | ||
| Q4 23 | — | $-595.0K | ||
| Q3 23 | — | $-647.0K | ||
| Q2 23 | — | $-1.7M | ||
| Q1 23 | — | $-1.2M |
| Q4 24 | — | -35.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -75.3% | ||
| Q4 23 | — | -28.3% | ||
| Q3 23 | — | -26.1% | ||
| Q2 23 | — | -48.3% | ||
| Q1 23 | — | -51.3% |
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.1% | ||
| Q4 23 | — | 0.1% | ||
| Q3 23 | — | 0.0% | ||
| Q2 23 | — | 0.1% | ||
| Q1 23 | — | 0.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GP
Segment breakdown not available.
NBY
| Other | $2.4M | 51% |
| Total Product Revenue | $2.3M | 49% |
